Cart
sales@molnova.com
CB2 modulator 1
CAS No. 666261-80-9
CB2 modulator 1 ( —— )
Catalog No. M26092 CAS No. 666261-80-9
CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 77 | Get Quote |
|
| 10MG | 109 | Get Quote |
|
| 25MG | 175 | Get Quote |
|
| 50MG | 256 | Get Quote |
|
| 100MG | 379 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCB2 modulator 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.
-
DescriptionCB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorS1P
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number666261-80-9
-
Formula Weight380.4
-
Molecular FormulaC18H19F3N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)(F)c1nc(Nc2ccccc2)ncc1C(=O)NCC1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hawkins JL, et al. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J Pharmacol Exp Ther. 2008 Sep;326(3):801-8.
molnova catalog
related products
-
Repertaxin
Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
-
JD-5037
A selective, peripherally restricted cannabinoid-1(CB1) receptor blocker with IC50 of 1.5 nM.
-
VCE-004.3
VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator.
